P39 DEDALO: PHASE II STUDY OF DARATUMUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE (DPD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND 17P DELETION

ABSTRACT:

SUBMITTER: Montefusco V 

PROVIDER: S-EPMC10171702 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature